Condomless Sex Among Virally Suppressed Women With HIV With Regular HIV-Serodiscordant Sexual Partners in the Era of Treatment as Prevention

Background: Sexual HIV transmission does not occur with sustained undetectable viral load (VL) on antiretroviral therapy (ART). Awareness of ART prevention benefits and its influence on condom use among women with HIV (WWH) remain unexplored. We estimated prevalence and correlates of condomless sex with regular HIV-serodiscordant partners among WWH with undetectable VL on ART. Methods: We used baseline questionnaire data from the community-based longitudinal Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS). We included WWH self-reporting vaginal/anal sex with ≥1 HIV-negative/unknown status regular partner within 6 months, and undetectable VL (<50 copies/mL) on ART. We excluded participants exclusively reporting female partners or missing condom-use data. Condomless sex was defined as <100% condom use within 6 months. The primary explanatory variable was awareness of ART prevention benefits. Logistic regression identified factors independently associated with condomless sex. Results: Of 271 participants (19% of the CHIWOS cohort), median age was 41 (interquartile range: 34–47), 51% were in a relationship, 55% reported condomless sex, and 75% were aware of ART prevention benefits. Among women aware, 63% reported condomless sex compared with 32% of women not aware (P < 0.001). Factors independently associated with condomless sex included being aware of ART prevention benefits (adjusted odds ratio: 4.08; 95% confidence interval: 2.04 to 8.16), white ethnicity, ≥high-school education, residing in British Columbia, and being in a relationship. Conclusions: Virally suppressed women aware of ART prevention benefits had 4-fold greater odds of condomless sex. Advancing safer sex discussions beyond condoms is critical to support women in regular serodiscordant partnerships to realize options for safe and satisfying sexuality in the Treatment-as-Prevention era.

[1]  M. Loutfy,et al.  Contraceptive Choice and Use of Dual Protection Among Women Living with HIV in Canada: Priorities for Integrated Care , 2017, Perspectives on sexual and reproductive health.

[2]  S. Trottier,et al.  Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study , 2017, BMC Research Notes.

[3]  S. Trottier,et al.  Establishing the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study (CHIWOS): Operationalizing Community-based Research in a Large National Quantitative Study , 2016, BMC Medical Research Methodology.

[4]  Pietro Vernazza,et al.  Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. , 2016, JAMA.

[5]  A. Persson.  'The world has changed': pharmaceutical citizenship and the reimagining of serodiscordant sexuality among couples with mixed HIV status in Australia. , 2016, Sociology of health & illness.

[6]  P. Vernazza,et al.  HIV is not transmitted under fully suppressive therapy: The Swiss Statement--eight years later. , 2016, Swiss medical weekly.

[7]  F. Lert,et al.  Sexual risk behaviour among people living with HIV according to the biomedical risk of transmission: results from the ANRS-VESPA2 survey , 2016, Journal of the International AIDS Society.

[8]  J. Kaldor,et al.  HIV transmission law in the age of treatment-as-prevention , 2015, Journal of Medical Ethics.

[9]  R. Hogg,et al.  Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada , 2015, BMC Infectious Diseases.

[10]  H. Günthard,et al.  Increases in Condomless Sex in the Swiss HIV Cohort Study , 2015, Open forum infectious diseases.

[11]  R. Hogg,et al.  Sexual inactivity and sexual satisfaction among women living with HIV in Canada in the context of growing social, legal and public health surveillance , 2015, Journal of the International AIDS Society.

[12]  A. Amin.  Addressing gender inequalities to improve the sexual and reproductive health and wellbeing of women living with HIV , 2015, Journal of the International AIDS Society.

[13]  R. Hogg,et al.  Process Monitoring of an HIV Treatment as Prevention Program in British Columbia, Canada , 2014, Journal of acquired immune deficiency syndromes.

[14]  R. Wolitski,et al.  HIV sexual transmission risk among serodiscordant couples: assessing the effects of combining prevention strategies , 2014, AIDS.

[15]  P. Winch,et al.  Where Does Treatment Optimism Fit in? Examining Factors Associated with Consistent Condom Use Among People Receiving Antiretroviral Treatment in Rio de Janeiro, Brazil , 2014, AIDS and Behavior.

[16]  R. Chou,et al.  Association between knowledge of HIV-positive status or use of antiretroviral therapy and high-risk transmission behaviors: Systematic review , 2014, AIDS care.

[17]  S. Quilliam.  Women, Sexuality and the Political Power of Pleasure: Sex, Gender and Empowerment , 2013, Journal of Family Planning and Reproductive Health Care.

[18]  Yiyun Chen.  Treatment-Related Optimistic Beliefs and Risk of HIV Transmission: A Review of Recent Findings (2009-2012) in an Era of Treatment as Prevention , 2013, Current HIV/AIDS Reports.

[19]  P. Rochon,et al.  Systematic Review of HIV Transmission between Heterosexual Serodiscordant Couples where the HIV-Positive Partner Is Fully Suppressed on Antiretroviral Therapy , 2013, PloS one.

[20]  A. Monforte,et al.  Inconsistent condom use among HIV-positive women in the “Treatment as Prevention Era”: data from the Italian DIDI study , 2013, Journal of the International AIDS Society.

[21]  N. Ayiga.  Rates and Predictors of Consistent Condom-use by People Living with HIV/AIDS on Antiretroviral Treatment in Uganda , 2012, Journal of health, population, and nutrition.

[22]  B. Spire,et al.  The “Swiss Statement”: Who knows about it? How do they know? What are its effects on people living with HIV/AIDS? , 2012, AIDS care.

[23]  M. Loutfy,et al.  Canadian HIV pregnancy planning guidelines. , 2012, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[24]  J. Baeten,et al.  A qualitative study of barriers to consistent condom use among HIV-1 serodiscordant couples in Kenya , 2012, AIDS care.

[25]  T. Flanigan,et al.  Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world , 2011, AIDS (London).

[26]  K. McDonald.  ‘The old-fashioned way’: conception and sex in serodiscordant relationships after ART , 2011, Culture, health & sexuality.

[27]  J. Brooks,et al.  HIV-1 RNA rectal shedding is reduced in men with low plasma HIV-1 RNA viral loads and is not enhanced by sexually transmitted bacterial infections of the rectum. , 2011, The Journal of infectious diseases.

[28]  J. Montaner.  Treatment as prevention—a double hat-trick , 2011, The Lancet.

[29]  J. Mullins,et al.  Genital HIV-1 RNA Predicts Risk of Heterosexual HIV-1 Transmission , 2011, Science Translational Medicine.

[30]  Jennifer A. Pellowski,et al.  Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention , 2011, Sexually Transmitted Infections.

[31]  R. Weber,et al.  Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  A. Persson,et al.  Reflections on the Swiss Consensus Statement in the context of qualitative interviews with heterosexuals living with HIV , 2010, AIDS care.

[33]  J. Montaner,et al.  No evidence of increased sexual risk behaviour after initiating antiretroviral therapy among people who inject drugs , 2010, AIDS.

[34]  Evan Wood,et al.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study , 2010, The Lancet.

[35]  M. Ross,et al.  HIV treatment optimism and unsafe anal intercourse among HIV-positive men who have sex with men: findings from the positive connections study. , 2010, AIDS education and prevention : official publication of the International Society for AIDS Education.

[36]  B. Olagbuji,et al.  Fertility preferences, condom use, and concerns among HIV‐positive women in serodiscordant relationships in the era of antiretroviral therapy , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[37]  Matthias Egger,et al.  Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis , 2009, AIDS.

[38]  P. Vernazza.  The debate continues: does ‘undetectable’ mean ‘uninfectious’? , 2009 .

[39]  M. Sweat,et al.  The impact of HIV treatment on risk behaviour in developing countries: A systematic review , 2007, AIDS care.

[40]  B. Eampokalap,et al.  Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy. , 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[41]  P. Stevens,et al.  "He won't use condoms": HIV-infected women's struggles in primary relationships with serodiscordant partners. , 2007, American journal of public health.

[42]  Mardge H. Cohen,et al.  Acquisition of new sexual partners among women with HIV infection: patterns of disclosure and sexual behavior within new partnerships. , 2007, AIDS Education and Prevention.

[43]  G. Rutherford,et al.  Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda , 2006, AIDS.

[44]  J. Bartlett,et al.  Highly active antiretroviral therapy and sexual risk behavior: A metaanalytic review , 2004 .

[45]  S. Gortmaker,et al.  Relationship power, condom use and HIV risk among women in the USA , 2002, AIDS care.

[46]  C. Ferrans,et al.  Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. , 2001, Research in nursing & health.

[47]  Mardge H. Cohen,et al.  Determinants of HIV-1 shedding in the genital tract of women , 2001, The Lancet.

[48]  H. Minkoff,et al.  Condom Use Consistency Associated With Beliefs Regarding HIV Disease Transmission Among Women Receiving HIV Antiretroviral Therapy , 2001 .

[49]  Deborah L. Rhode.  Feminist Critical Theories , 1990 .

[50]  R. Khosla,et al.  Human Rights and the Sexual and Reproductive Health of Women Living with HIV: A Literature Review , 2015 .

[51]  R. Kaul,et al.  Canadian consensus statement on HIV and its transmission in the context of criminal law , 2014, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[52]  P. Iversen,et al.  Exploring contraceptive use differentials in Sub-Saharan Africa through a workforce lens. , 2013 .

[53]  Angela M Caliendo,et al.  Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load. , 2011, AIDS.

[54]  Enos Bernasconi,et al.  PERSONNES SEROPOSITIVES NE SOUFFRANT DAUCUNE AUTRE MST ET SUIVANT UN TRAITEMENT ANTIRETROVIRAL EFFICACE NE TRANSMETTENT PAS LE HIV PAR VOIE SEXUELLE , 2008 .

[55]  T. Templin,et al.  Stigma scale revised: reliability and validity of a brief measure of stigma for HIV+ youth. , 2007, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[56]  S. Weller,et al.  Condom effectiveness in reducing heterosexual HIV transmission. , 2002, The Cochrane database of systematic reviews.

[57]  S. Kippax,et al.  'If it's not on...': heterosexuality for HIV positive women , 1996 .